Pharma

Elix, an AI Drug Discovery Company, and Tohoku University Enter Joint Research Agreement to Advance AI Drug Discovery

Elix, Inc. and the Graduate School of Life Sciences at Tohoku University  are pleased to announce the signing of a joint research agreement aimed at advancing drug discovery using AI technologies. Traditional drug discovery processes require considerable time and cost to identify promising compounds from among a vast number of candidates, yet still face low success rates as a major challenge. Against this backdrop, the introduction of AI is drawing attention as a transformative approach to improving the efficiency of drug discovery research. In particular, the application of AI to molecular design and property prediction makes it possible to more accurately design drug candidates and narrow down synthesis and evaluation targets, thereby accelerating development and reducing costs from the early discovery stage onward. Elix is a Japan-based AI drug discovery…